Sylvie NEGRIER MD PhD, Medical Oncologist at the Comprehensive Cancer Center in Lyon, France, Professor of Medical Oncology at Lyon I University. Expert in advanced renal carcinoma since more than 25 years, lead of several international and national clinical trials on targeted therapies and immunotherapy with more than 300 publications in the field of Oncology.

Professor Négrier’s principal research interest is the use of immunotherapy and targeted therapies in the treatment of malignant melanoma and metastatic renal cell carcinoma. She is a member of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Professor Négrier is particularly involved with Groupe d’Etude des Cancers Urologiques, where she has acted as principal investigator for several multicentre trials investigating the use of immunotherapy and targeted therapies in renal carcinoma with more than 300 publications in the field of Oncology.